These findings significantly advance our understanding of the mechanisms by which SDF-1 contributes to the pathogenesis of colon cancer and provide a solid basis for future investigations aimed at targeting this pathway as a therapeutic strategy. This evidence concerns the gene CXCL12 and malignant colon neoplasm.